The Cost-Effectiveness of Continuous Erythropoiesis Receptor Activator Once Monthly versus Epoetin Thrice Weekly for Anaemia Management in Chronic Haemodialysis Patients

Introduction. The aim of this study was to compare the cost-effectiveness of continuous erythropoietin receptor activator (CERA) once monthly to epoetin beta (EpoB) thrice weekly to maintain haemoglobin (Hb) within the range 10.5–12 g/dL. Methods. Prospective cohort study and cost-effectiveness anal...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Anemia
Autori principali: Maoujoud, Omar, Ahid, Samir, Dkhissi, Hocein, Oualim, Zouhair, Cherrah, Yahia
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi Publishing Corporation 2015
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4710935/
https://ncbi.nlm.nih.gov/pubmed/26843983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/189404
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi